Introduction to 11c Choline Pet Ct

What is/are 11c Choline Pet Ct?

11c Choline Pet Ct - Material and methods A single center retrospective study comprising of 30 patients who underwent retroperitoneal and/or pelvic salvage lymph node dissection (LND) due to 11C-choline PET/CT-positive nodal recurrences after radical treatment (median Prostate Specific Antigen (PSA) 1. ^[1] We report site-specific relapse patterns of post-prostatectomy patients with BCR assessed by 68Ga-PSMA-11 or 11C-Choline PET/CT and investigated the impact of postoperative androgen deprivation therapy (ADT) and radiotherapy (RT) on the anatomic distribution of relapse. ^[2] We report site-specific relapse patterns of post-prostatectomy patients with BCR assessed by 68Ga-PSMA-11 or 11C-Choline PET/CT and investigated the impact of postoperative androgen deprivation therapy(ADT) and radiotherapy(RT) on the anatomic distribution of relapse. ^[3] We report an unusual case of a solitary prostatic metastasis in the spermatic cord, following robotic-assisted laparoscopic radical prostatectomy with pelvic lymph node dissection and salvage radiotherapy, detected with the use of 11C-Choline PET/CT, heralded by a progressive rise in PSA. ^[4] The highest organ equivalent dose was to kidney for18F-Choline and68Ga-PSMA PET/CT scans and thyroid for11C-Choline PET/CT scan. ^[5] BACKGROUND AND OBJECTIVES: To prospectively compare the detection rate of 68Ga-DOTATATE versus 11C-choline PET/CT in patients with prostate cancer in biochemical relapse, and to evaluate somatostatin receptor expression in vivo to plan targeted therapies (177Lu-DOTATATE). ^[6] Our aim was to evaluate the effect of positive 11C-choline PET/CT results in the therapeutic management of patients with PCa with biochemical relapse (BR) after curative intention treatment. ^[7] Therefore, we evaluated consecutive 68Ga-prostate-specific membrane antigen (PSMA) PET/CT, 11C-choline PET/CT, and standard CT imaging in the same patient with regard to TNM-stage migration and accordingly adapted curative radiotherapy options including ablative treatment of oligometastases (n ≤ 5). ^[8] We performed 34 11C-choline PET/CT scans before/after a combined total of 17 courses of treatment in 6 patients with prostate cancer and 2 with renal cell carcinoma. ^[9] Four observers analyzed the 11C-choline PET/CT in four randomized rounds for all patients. ^[10] 9%) received SyS (ADT or chemotherapy) for LN-only CRPCa recurrence after radical prostatectomy (RP) detected at 11C-choline PET/CT (01/1990-01/2016). ^[11] PurposeCarbon 11-choline positron emission tomography/computed tomography (11C-choline PET/CT) and subsequent local therapy for oligometastatic prostate cancer have been reported to be effective, but their effectiveness in castration-resistant prostate cancer (CRPC) remains unclear. ^[12]